Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy

Pediatric Dermatology

Volumn 26, Issue 5, 2009, Pages 579-582

  Foss, Clare ^a   Smith, Jeff K ^b   Ortiz, Luis ^b   Hanevold, Coral ^b   Davis, Loretta ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; DOXORUBICIN; GADODIAMIDE; GROWTH HORMONE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CHILD; CHRONIC KIDNEY FAILURE; COMPRESSION GARMENT; GROWTH RETARDATION; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PUNCH BIOPSY; SCHOOL CHILD;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; GADOLINIUM; HUMANS; KIDNEY FAILURE, ACUTE; MAGNETIC RESONANCE IMAGING; MALE; NEPHROGENIC FIBROSING DERMOPATHY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SKIN;

EID: 70350023182     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00802.x     Document Type: Article

References (17)

1. Cowper SE, Su LD, Bhawan J et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001 23 : 383 393.
2. Ting WW, Stone MS, Madison KC et al. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003 139 : 903 906.
3. Kucher C, Steere J, Elenitsas R et al. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J Am Acad Dermatol 2006 54 : S31 S34.
4. Streams BN, Liu V, Liegeois N et al. Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. J Am Acad Dermatol 2003 48 : 42 47.
5. Galan A, Cowper SE, Bucala R. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol 2006 18 : 614 617.
6. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006 21 : 1104 1108.
7. Marckmann P, Skov L, Rossen K et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006 17 : 2359 2362.
8. High WA, Ayers RA, Chandler J et al. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007 56 : 21 26.
9. Boyd AS, Zic JA, Abraham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007 56 : 27 30.
10. Grobner T, Prischl FC. Gadolinium and nephrogenic systemic fibrosis. Kidney Int 2007 72 : 260 264.
11. Swaminathan S, Horn TD, Pellowski D et al. Nephrogenic systemic fibrosis, gadolinium and iron mobilization. N Engl J Med 2007 357 : 720 722. (Pubitemid 47267261)
12. Parsons AC, Yosipovitch G, Sheehan DJ et al. Transglutaminases: the missing link in nephrogenic systemic fibrosis. Am J Dermatopathol 2007 29 : 433 436.
13. Auron A, Shao L, Warady BA. Nephrogenic fibrosing dermopathy in children. Pediatr Nephrol 2006 21 : 1307 1311.
14. Jan F, Segal JM, Dyer J et al. Nephrogenic fibrosing dermopathy: two pediatric cases. J Pediatr 2003 143 : 678 681.
15. Jain SM, Wesson S, Hassanein A et al. Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 2004 19 : 467 470.
16. DiCarlo JB, Gupta EA, Solomon AR. A pediatric case of nephrogenic fibrosing dermopathy: improvement after combination therapy. J Am Acad Dermatol 2006 54 : 914 916.
17. Dharnidharka VR, Wesson SK, Fennell RS. Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 2007 22 : 1395.